Latest News and Press Releases

PALO ALTO, Calif., May 22, 2026 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative revenue-generating company focused on acquiring, developing, and...

SINGAPORE, May 22, 2026 (GLOBE NEWSWIRE) -- VS Media Holdings Limited (NASDAQ: VSME) (“VS Media” or the “Company”), a company managing a global network of digital Creators who create and publish...

SINGAPORE, May 22, 2026 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) (“Cuprina” or “the Company”), a biomedical company developing and marketing products for the chronic...

Taipei, Taiwan, May 22, 2026 (GLOBE NEWSWIRE) -- SemiLux International Ltd. (Nasdaq: SELX) (the "Company") today announced that, on May 19, 2026, the Company received a Staff Determination Letter...

LOS ANGELES, May 22, 2026 (GLOBE NEWSWIRE) -- XMax Inc. (NASDAQ: XWIN, the “Company” or “XMax”) today announced that its wholly owned subsidiary, XMax AI Inc. (“XMax AI”), has entered into an...

News highlights: Micron starts manufacturing of 1α (1-alpha) DRAM, the most advanced memory ever produced in the United States, at its Manassas, Virginia, fab, supporting American memory production...

ATHENS, Greece, May 22, 2026 (GLOBE NEWSWIRE) -- IMPERIAL PETROLEUM INC. (NASDAQ: IMPP; the “Company”), a ship-owning company providing petroleum products, crude oil and dry bulk seaborne...

PYRUKYND (mitapivat) approved in the European Union for adults with thalassemia

HONG KONG, May 22, 2026 (GLOBE NEWSWIRE) -- Futu Holdings Limited ("Futu" or the "Company") (Nasdaq: Futu), today announced that the Company received a Notice of Investigation and an Administrative...

Translational data demonstrate induction of both innate and adaptive antiviral and anti-tumor specific immune responses capable of controlling tumor growth